Skip to main content
Fig. 5 | Molecular Pain

Fig. 5

From: KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia

Fig. 5

Alleviation of oxaliplatin-induced orofacial cold hyperalgesia by retigabine. Bar graph shows total contact time of orofacial operant tests for oxaliplatin-injected rats under the following conditions: 24, 12, 12°C with vehicle injection, 12°C with retigabine treatment at the dose of 0.19, 0.56, 1.67, and 15 mg/kg. Retigabine was administered intraperitoneally to the animals. Data represent Mean ± SEM, ***P < 0.01.

Back to article page

Molecular Pain

ISSN: 1744-8069

Contact us